Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6087.0000
-21.00
(
-0.34
%)
NSE
Apr 30, 2025
15:31 PM
New 52W High in past week
Volume:
489.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
15 Aug 2022
6087.00
-0.34%
DIVI'S LABORATORIES
Accumulate:
Divi's Laboratories Ltd.
by
Prabhudas Lilladhar
Target: 4140
Target
Prabhudas Lilladhar
Number of FII/FPI investors increased from 826 to 922 in Mar 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended
Upcoming results tracker: Stocks outperforming their industries in Q3 results, with strong Forecaster estimates for Q4
The Baseline |
30 Apr 2025, 05:28PM
Market closes flat, Vedanta's net profit grows 154.4% YoY to Rs 3,483 crore in Q4
Trendlyne Marketwatch |
30 Apr 2025, 03:56PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022